Cargando…

The Antiepileptic Drug and Toxic Teratogen Valproic Acid Alters Microglia in an Environmental Mouse Model of Autism

Autism spectrum disorder (ASD), a neurodevelopmental condition affecting approximately 1 in 44 children in North America, is thought to be a connectivity disorder. Valproic acid (VPA) is a multi-target drug widely used to treat epilepsy. It is also a toxic teratogen as well as a histone deacetylase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Triyasakorn, Korawin, Ubah, Ubah Dominic Babah, Roan, Brandon, Conlin, Minsyusheen, Aho, Ken, Awale, Prabha S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319720/ https://www.ncbi.nlm.nih.gov/pubmed/35878284 http://dx.doi.org/10.3390/toxics10070379

Ejemplares similares

Pan HDACi Valproic Acid and Trichostatin A Show Apparently Contrasting Inflammatory Responses in Cultured J774A.1 Macrophages
por: Ubah, Ubah Dominic Babah, et al.
Publicado: (2022)

Teratogenicity of Antiepileptic Drugs
por: Güveli, Betül Tekin, et al.
Publicado: (2017)

Teratogenic Potential of Antiepileptic Drugs in the Zebrafish Model
por: Lee, Sung Hak, et al.
Publicado: (2013)

Valproic Acid Teratogenicity: A Toxicogenomics Approach
por: Kultima, Kim, et al.
Publicado: (2004)

Neurological teratogenic effects of antiepileptic drugs during pregnancy
por: Nie, Qingmei, et al.
Publicado: (2016)

Antiepileptic Drugs as Teratogens: The Mechanism Remains a Mystery
por: Mefford, Heather C.
Publicado: (2020)

Mitochondrial Toxic Effects of Antiepileptic Drug Valproic Acid on Mouse Kidney Stem Cells
por: Lee, Minsu, et al.
Publicado: (2023)

Chronotolerance study of the antiepileptic drug valproic acid in mice
por: Ben-Cherif, Wafa, et al.
Publicado: (2012)

The Proteomic and Genomic Teratogenicity Elicited by Valproic Acid Is Preventable with Resveratrol and α-Tocopherol
por: Chen, Yeh, et al.
Publicado: (2014)

The how of leadership: inspire people to achieve extraordinary results
por: Ubah, Maxwell
Publicado: (2018)

The potential antiepileptic activity of astaxanthin in epileptic rats treated with valproic acid
por: Ata Yaseen Abdulqader, Yussra, et al.
Publicado: (2021)

The Embryonic Stem Cell Test as Tool to Assess Structure-Dependent Teratogenicity: The Case of Valproic Acid
por: Riebeling, Christian, et al.
Publicado: (2011)

Monoclonal Antibodies and Antibody Like Fragments Derived from Immunised Phage Display Libraries
por: Ubah, Obinna, et al.
Publicado: (2018)

Teratogenicity, mutagenicity, and cellular toxicity of phthalate esters.
por: Dillingham, E O, et al.
Publicado: (1973)

Thresholds in toxic, teratogenic, mutagenic, and carcinogenic effects.
por: Freese, E
Publicado: (1973)

The perils of antiepileptic toxicity
por: Madan, Arushi, et al.
Publicado: (2020)

Reduction in mortality and teratogenicity following simultaneous administration of folic acid and vitamin E with antiepileptic, antihypertensive and anti-allergic drugs
por: Wahid, Shahana, et al.
Publicado: (2014)

The Antiepileptic Drug Valproic Acid Restores T Cell Homeostasis and Ameliorates Pathogenesis of Experimental Autoimmune Encephalomyelitis
por: Lv, Jie, et al.
Publicado: (2012)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

Teratogenicity and hyperprolactinemia
por: Andrade, Chittaranjan
Publicado: (2009)

Teratogenicity with Olanzapine
por: Prakash, Sathya, et al.
Publicado: (2014)

Reduced Adult Hippocampal Neurogenesis and Cognitive Impairments following Prenatal Treatment of the Antiepileptic Drug Valproic Acid
por: Juliandi, Berry, et al.
Publicado: (2015)

The Effect of Coenzyme Q10 on Liver Injury Induced by Valproic Acid and Its Antiepileptic Activity in Rats
por: Alqarni, Fahad, et al.
Publicado: (2022)

Blindness and Visual Impairment among Adults in a Tertiary Eye Clinic, in Osogbo S W Nigeria
por: Isawumi, MA, et al.
Publicado: (2014)

The telestroke and thrombolysis therapy in diabetic stroke patients
por: Nathaniel, Thomas I., et al.
Publicado: (2019)

In Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA: An Encouraging Milestone to Further Clinical Drug Development
por: Ubah, Obinna C., et al.
Publicado: (2020)

Awareness and Attitudes of Art Students and Lecturers on Health Hazards Associated With Fine and Applied Arts Making in Nigeria
por: Ibenegbu, Christopher Ifeanyi, et al.
Publicado: (2021)

Antioxidant Phytochemicals as Potential Therapy for Diabetic Complications
por: Akpoveso, Oke-Oghene Philomena, et al.
Publicado: (2023)

Catalog of Teratogenic Agents
por: Craig, A. W.
Publicado: (1974)

Catalog of Teratogenic Agents
por: Craig, A. W.
Publicado: (1980)

Catalog of Teratogenic Agents
por: Craig, A. W.
Publicado: (1977)

Teratogenicity and Antiseizure Medications
por: Meador, Kimford
Publicado: (2020)

Teratogenicity of D-allulose
por: Sa, Soonok, et al.
Publicado: (2022)

Exploring the Validity of Valproic Acid Animal Model of Autism
por: Mabunga, Darine Froy N., et al.
Publicado: (2015)

Modulation of Antioxidant Enzymatic Activities by Certain Antiepileptic Drugs (Valproic Acid, Oxcarbazepine, and Topiramate): Evidence in Humans and Experimental Models
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2013)

Toxic and Teratogenic Effects of Prenatal Alcohol Exposure on Fetal Development, Adolescence, and Adulthood
por: Chung, Dae D., et al.
Publicado: (2021)

Molecular and Therapeutic Potential and Toxicity of Valproic Acid
por: Chateauvieux, Sébastien, et al.
Publicado: (2010)

Severe Hyponatremia Due to Valproic Acid Toxicity
por: Gupta, Ena, et al.
Publicado: (2015)

Thrombotic microangiopathy associated with Valproic acid toxicity
por: Hebert, Sean A., et al.
Publicado: (2017)

Therapeutic and Toxic Effects of Valproic Acid Metabolites
por: Shnayder, Natalia A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ukock9uim9mp3i974grvsntc5o